bioRxivPhysiologyPreprint
Collagen content and cross-links scale with passive stiffness in dystrophic mouse muscles, but are not altered with administration of collagen cross-linking inhibitor beta-aminopropionitrile
S. E. Brashear, R. P. Wohlgemuth, L.-Y. R. Hu, E. H. Jbeily, B. A. Christiansen, L. R. Smith
Abstract
In Duchenne muscular dystrophy (DMD), a lack of functional dystrophin leads to myofiber instability and progressive muscle damage that results in fibrosis. While fibrosis is primarily characterized by an accumulation of extracellular matrix (ECM) components, there are changes in ECM architecture during fibrosis that relate more closely to functional muscle stiffness. One of these architectural changes in dystrophic muscle is collagen cross-linking, which has been shown to increase the passive muscle stiffness in models of fibrosis including the mdx mouse, a model of DMD. We tested whether the intraperitoneal injections of beta-aminopropionitrile (BAPN), an inhibitor of the cross-linking enzyme lysyl oxidase, would reduce collagen cross- linking and passive stiffness in young and adult mdx mice compared to saline-injected controls. We found no significant differences between BAPN treated and saline treated mice in collagen cross-linking and stiffness parameters. However, we observed that while collagen cross-linking and passive stiffness scaled positively in dystrophic muscles, collagen fiber alignment scaled with passive stiffness distinctly between muscles. We also observed that the dystrophic diaphragm showed the most dramatic fibrosis in terms of collagen content, cross-linking, and stiffness. Overall, we show that while BAPN was not effective at reducing collagen cross- linking, the positive association between collagen cross-linking and stiffness in dystrophic muscles still show cross-linking as a viable target for reducing passive muscle stiffness in DMD or other fibrotic muscle conditions. Key PointsO_LIBAPN did not reduce collagen cross-linking or passive stiffness in any muscle C_LIO_LICollagen cross-links scaled with passive stiffness in dystrophic muscles C_LIO_LIThe mdx diaphragm showed the most dramatic fibrosis related to collagen content, cross- linking, and passive stiffness C_LIO_LICollagen fiber alignment scales with passive stiffness differently between muscles C_LI
- organism: mouse
- research focus: host-pathogen & immune response
- research focus: development & morphogenesis
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Diaphragm muscle fibrosis involves changes in collagen organization with mechanical implications in Duchenne Muscular Dystrophy
R. Sahani, C. H. Wallace, … S. S. Blemker·bioRxiv·Apr 7, 2021
- Distinct extracellular matrix states uncouple collagen accumulation from pathological fibrosis in Duchenne muscular dystrophy
Pranav Kannan, Daniel Helzer, … Rachelle H. Crosbie·bioRxiv·Aug 19, 2026
- Dystrophin-deficiency stiffens skeletal muscle and impairs elasticity: an in vivo rheological examination
Pavithran Devananthan, Rebecca Craven, … Angus Lindsay·Journal of Applied PhysiologyPeer-reviewed·Dec 1, 2025
- Fibrotic-like collagen matrices as innovative 3D in vitro models for investigating the impact of pathological ECM on muscle regeneration in muscular dystrophies
Marie Camman, Naomi Nieswic, … Christophe Hélary·Biomaterials SciencePeer-reviewed·Jan 1, 2026
- The adiponectin analogue ALY688-SR attenuates diaphragm fibrosis, atrophy and mitochondrial stress in a mouse model of Duchenne muscular dystrophy
C. A. Bellissimo, S. Gandhi, … C. G. Perry·bioRxiv·May 22, 2023
- Laminin-α2 is required for the maintenance of the myotendinous junction in vivo
Julia Schedel, Shuo Lin, … Markus A. Rüegg·Matrix BiologyPeer-reviewed·Mar 17, 2026